QUOTE AND NEWS
Bloomberg  Jun 16  Comment 
(Update1) Boehringer Ingelheim GmbH’s sexual desire drug flibanserin may not be effective or safe, according to U.S. regulators weighing whether to approve the first pill designed to boost women’s libidos.
MarketWatch  May 27  Comment 
Swiss drugmaker Novartis said Thursday that patupilone did not show a significant overall survival advantage in a phase III trial of patients with advanced ovarian cancer, refractory or resistant to platinum-based therapy. The primary endpoint of...
MarketWatch  Feb 22  Comment 
Swiss drug firm Novartis said Monday that Menveo, a quadrivalent meningococcal conjugate vaccine, was approved by the U.S. Food and Drug Administration. The medicine was approved for active immunization. Market Pulse Stories are Rapid-fire,...
Bloomberg  Nov 13  Comment 
(Update1) Boehringer Ingelheim GmbH is banking on sex really being all in women’s heads.
MarketWatch  Sep 15  Comment 
Novartis, the Basel health-care giant, said on Tuesday that results from Phase III trials showed that QAB149, generically indacaterol, in testing as a once-daily bronchodilator for chronic obstructive pulmonary disease, "significantly improves...
StreetInsider.com  Aug 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/S%26P+Announces+Update+to+US+Indices+Liquidity+Criteria%3B+SIGM+to+Replace+NOVN/4886863.html for the full story.
Bloomberg  Aug 7  Comment 
(Update2) BioSante Pharmaceuticals Inc., the developer of a gel to treat female sexual dysfunction, aims to fund clinical trials with cash from its planned acquisition of Cell Genesys Inc., a developer of cancer vaccines.
Motley Fool  Jul 23  Comment 
It can pay to catch rising stars.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki